Chen, Zhangjie
Zhen, Sisi
Sun, Jiali
Zhou, Lukun
Zhang, Tingting
Shen, Yuyan
Guo, Wenjing
Zheng, Yizhou
Zhang, Fengkui
Mi, Yingchang
Qiu, Lugui
Zhu, Xiaofan
Jiang, Erlie
Han, Mingzhe
Xiao, Zhijian
Wang, Jianxiang
Feng, Sizhou
Chen, Xin
Funding for this research was provided by:
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-1-060, 2021-I2M-1-017)
Special Fund Project for Science and Technology Innovation Strategy of Nanjing (YKK21273)
Research Personnel Cultivation Programme of Zhongda Hospital Southeast University (CZXM-GSP-RC20)
Tianjin Municipal Science and Technology Commission Grant (21JCZDJC01170)
Beijing Xisike Clinical Oncology Research Foundation (Y-SYBLD2022RWR-0017)
Article History
Received: 10 September 2024
Accepted: 1 April 2025
First Online: 15 April 2025
Declarations
:
: The authors declare no competing interests.
: This research was approved by the ethical committee of the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (reference number: IIT2022071-EC-1), and informed consent forms were obtained from all patients. The study was performed in accordance with the Declaration of Helsinki.